TITLE

Insulin Receptor Expression in Clear Cell Renal Cell Carcinoma and Its Relation to Prognosis

AUTHOR(S)
Lkhagvadorj, Sayamaa; Sung Soo Oh; Mi-Ra Lee; Jae Hung Jung; Hyun Chul Chung; Seung-Kuy Cha; Minseob Eom
PUB. DATE
June 2014
SOURCE
Yonsei Medical Journal;Jun2014, Vol. 55 Issue 4, p861
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Purpose: Both insulin and insulin-like growth factor (IGF)-1 signaling are key regulators of energy metabolism, cellular growth, proliferation, and survival. The IGF-1 receptor (IGF-1R) is overexpressed in most types of human cancers including renal cell carcinoma (RCC) with poor prognosis. Insulin receptor (IR) shares downstream effectors with IGF-1R; however, the expression and function of IR in the tumorigenesis of renal cancer remains elusive. Therefore, we examined the expression of IR and its prognostic significance in clear cell RCC (CCRCC). Materials and Methods: Immunohistochemical staining for IR was performed on 126 formalin-fixed paraffin-embedded CCRCC tissue samples. Eight of these cases were utilized for western blot analysis. The results were compared with various clinico-pathologic parameters of CCRCC and patient survival. Results: IR was expressed in the nuclei of CCRCC tumor cells in 109 cases (87.9%). Higher IR expression was significantly correlated with the presence of cystic change, lower Fuhrman nuclear grade, lower pathologic T stage, and lower TNM stage, although it wasn't significantly related to diabetes status and patient survival. Western blot analyses supported the results of the immunohistochemistry studies. Conclusion: IR expression in CCRCC may be associated with favorable prognostic factors.
ACCESSION #
96805117

 

Related Articles

  • Insulin Receptor Expression in Clear Cell Renal Cell Carcinoma and Its Relation to Prognosis. Lkhagvadorj, Sayamaa; Sung Soo Oh; Mi-Ra Lee; Jae Hung Jung; Hyun Chul Chung; Seung-Kuy Cha; Minseob Eom // Yonsei Medical Journal;Jul2014, Vol. 55 Issue 4, p861 

    Purpose: Both insulin and insulin-like growth factor (IGF)-1 signaling are key regulators of energy metabolism, cellular growth, proliferation, and survival. The IGF-1 receptor (IGF-1R) is overexpressed in most types of human cancers including renal cell carcinoma (RCC) with poor prognosis....

  • Insulin-like growth factor-1 signaling in renal cell carcinoma. Tracz, Adam F.; Szczylik, Cezary; Porta, Camillo; Czarnecka, Anna M. // BMC Cancer;7/12/2016, Vol. 16, p1 

    Renal cell carcinoma (RCC) incidence is highest in highly developed countries and it is the seventh most common neoplasm diagnosed. RCC management include nephrectomy and targeted therapies. Type 1 insulin-like growth factor (IGF-1) pathway plays an important role in cell proliferation and...

  • Akt signalling parameters are different in oncocytomas compared to renal cell carcinoma. Amend, B.; Hennenlotter, J.; Scharpf, M.; Kruck, S.; Kuehs, U.; Senger, E.; Merseburger, A.; Kuczyk, M.; Sievert, K.; Stenzl, A.; Bedke, J. // World Journal of Urology;Jun2012, Vol. 30 Issue 3, p353 

    Purpose: Renal oncocytomas are assigned as benign tumours, and their detailed molecular mechanism is poorly characterised. Activation of the PKB/Akt pathway is assumed to contribute to the pathogenesis and progression of malignant disease. For oncocytomas, hardly any data are available for Akt...

  • Phosphorylated Signal Transducer and Activator of Transcription 1 is a potential predictor of interferon response in patients with advanced renal cell carcinoma. WEI LI; QIANG WEI; JIANBO LIANG // Molecular Medicine Reports;2014, Vol. 9 Issue 5, p1929 

    The present study aimed to evaluate the expression status of Janus kinase (JAK)-Signal Transducer and Activator of Transcription (STAT) in renal cell carcinoma and benign renal tissue, and identify a potential biomarker for interferon (IFN) response prediction. A total of 32 specimens of human...

  • The role of CXC-chemokine receptor CXCR2 and suppressor of cytokine signaling-3 (SOCS-3) in renal cell carcinoma. Stofas, Anastasios; Levidou, Georgia; Piperi, Christina; Adamopoulos, Christos; Dalagiorgou, Georgia; Bamias, Aristotelis; Karadimou, Alexandra; Lainakis, George A.; Papadoukakis, Stefanos; Stravodimos, Konstantinos; Dimopoulos, Meletios-Athanasios; Patsouris, Efstratios; Gakiopoulou, Hariklia; Korkolopoulou, Penelope // BMC Cancer;2014, Vol. 14 Issue 1, p1 

    Background Chemokine receptor signaling pathways are implicated in the pathobiology of renal cell carcinoma (RCC). However, the clinical relevance of CXCR2 receptor, mediating the effects of all angiogenic chemokines, remains unclear. SOCS (suppressor of cytokine signaling)-3 is a negative...

  • The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in renal cell carcinoma. Erdem, Selcuk; Yegen, Gulcin; Telci, Dilek; Yildiz, Ibrahim; Tefik, Tzevat; Issever, Halim; Kilicaslan, Isin; Sanli, Oner // World Journal of Urology;Oct2015, Vol. 33 Issue 10, p1553 

    Purpose: The aim of this study was to investigate the role of transglutaminase 2(TG2) in renal cell carcinoma (RCC) by comparing the immunohistochemistry staining of primary and metastatic tumor tissues. Methods: A total of 33 metastatic RCC(mRCC) and 33 non-metastatic RCC (nmRCC) patients who...

  • The impact of immunohistochemical expression of nitric oxide synthases on clinical and pathological features of renal cell carcinoma. Cássio Zequi, Stênio; Fregnani, José; Favaretto, Ricardo; Costa, Walter; Madeira Campos, Rodrigo; Fonseca, Francisco; Guimaraes, Gustavo; Soares, Fernando; Cunha, Isabela; Lopes, Ademar // World Journal of Urology;Oct2013, Vol. 31 Issue 5, p1197 

    Purpose: To evaluate the immunohistochemical expression of nitric oxide synthase (NOS) types 1, 2, and 3 in intratumoral and non-neoplastic samples of renal cell carcinoma (RCC) and correlate it with the clinical and pathological features of this malignancy. Methods: We analyzed 110 patients...

  • Skp2 Regulates Subcellular Localization of PPARγ by MEK Signaling Pathways in Human Breast Cancer. Hongge Cheng; Jie Meng; Guisheng Wang; Yuming Meng; Yu Li; Dong Wei; Chunyun Fu; Kaifeng Deng; Aiguo Shen; Huimin Wang; Shengming Dai // International Journal of Molecular Sciences;Aug2013, Vol. 14 Issue 8, p16554 

    Nuclear hormone receptor family member PPARγ plays an important role in mammary gland tumorigenesis. Previous studies have shown PPARγ has cytoplasmic activities upon tetradecanoyl phorbol acetate (TPA) stimulation. However, the clinical pathological significance of cytoplasmic PPARγ is...

  • Insulin activates the insulin receptor to downregulate the PTEN tumour suppressor. Liu, J; Visser-Grieve, S; Boudreau, J; Yeung, B; Lo, S; Chamberlain, G; Yu, F; Sun, T; Papanicolaou, T; Lam, A; Yang, X; Chin-Sang, I // Oncogene;7/17/2014, Vol. 33 Issue 29, p3878 

    Insulin and insulin-like growth factor-1 signaling have fundamental roles in energy metabolism, growth and development. Recent research suggests hyperactive insulin receptor (IR) and hyperinsulinemia are cancer risk factors. However, the mechanisms that account for the link between the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics